![]() | PYFA - Pyridam Farma Tbk | PYFA - Pyridam Farma Tbk | PYFA - Pyridam Farma Tbk | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Board | : | 4 Index COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ![]() |
|||||
F Poor | ||||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING FUNDAMENTAL | ||
---|---|---|
Rating EPS | 0 | |
Rating ROA | 1 | |
Rating EQUITY | 2 | |
Rating ROE | 0 | |
Rating DER | 2 | |
Rating TOTAL | 1 |
MARKET CAPITALIZATION | ||
Listed Share | 11.236.681.881 | |
Price | Rp. 232 | |
Capitalization | Rp. 2.606.910.196.392 | |
OWNERSHIP | ||
Listing Date : 16-OCT-2001 | ||
Lokal 34,41 % | Asing 65,59 % | Lainnya 0,00 % |
![]() | PYFA - Pyridam Farma Tbk | PYFA - Pyridam Farma Tbk | PYFA - Pyridam Farma Tbk | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Board | : | 4 Index COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
Description | 4Q18 | 4Q19 | 4Q20 | 4Q21 | 4Q22 | 4Q23 | 4Q24 | CAGR 5Y(%) |
Last Price | 189 | 198 | 975 | 1015 | 865 | 1145 | 142 | |
Market Cap | 101.1 B | 105.9 B | 521.7 B | 543.1 B | 462.8 B | 612.7 B | 1.6 T | 1410.86 |
BALANCE SHEET | ||||||||
Cash | 2.0 B | 5.3 B | 9.6 B | 47.7 B | 136.6 B | 90.0 B | 351.9 B | 6539.62 |
Total Asset | 187.1 B | 190.8 B | 228.6 B | 806.2 B | 1.5 T | 1.5 T | 5.8 T | 2939.83 |
S.T.Borrowing | 33.1 B | 27.2 B | 44.7 B | 251.8 B | 297.4 B | 293.7 B | 1.2 T | |
L.T.Borrowing | 35.0 B | 38.9 B | 26.2 B | 387.3 B | 780.8 B | 870.5 B | 3.6 T | |
Total Equity | 118.9 B | 124.7 B | 157.6 B | 167.1 B | 442.4 B | 357.1 B | 1.0 T | 701.92 |
INCOME STATEMENT | ||||||||
Revenue | 250.4 B | 247.1 B | 277.4 B | 630.5 B | 715.4 B | 702.1 B | 1.9 T | 668.92 |
Gross Profit | 151.1 B | 140.2 B | 163.9 B | 244.6 B | 250.8 B | 295.3 B | 536.5 B | 282.67 |
Operating Profit | 14.5 B | 15.3 B | 32.1 B | 51.9 B | 345.9 B | 1.9 B | -106.9 B | -798.69 |
Net.Profit | 8.4 B | 9.3 B | 22.1 B | 5.5 B | 275.2 B | -85.2 B | -330.2 B | -3650.54 |
EBITDA | 21.8 B | 22.7 B | 34.2 B | 60.5 B | 360.9 B | 15.2 B | -36.7 B | -261.67 |
Interest Expense | 3.2 B | 2.8 B | 2.6 B | 43.4 B | 87.1 B | 86.5 B | 226.0 B | |
RATIO | ||||||||
EPS | 15.79 | 17.46 | 41.31 | 10.24 | 514.37 | -159.26 | -29.49 | -268.90 |
PER | 11.97 x | 11.34 x | 23.60 x | 99.12 x | 1.68 x | -7.19 x | -4.82 x | |
BVPS | 222.26 | 233.1 | 294.59 | 312.29 | 826.71 | 667.3 | 92.51 | |
PBV | 0.85 x | 0.85 x | 3.31 x | 3.25 x | 1.05 x | 1.72 x | 1.53 x | |
ROA | 0.0452 | 0.049 | 0.0967 | 0.0068 | 0.181 | -0.056 | -0.0568 | -215.92 |
ROE | 0.071 | 0.0749 | 0.1402 | 0.0328 | 0.6222 | -0.2387 | -0.3177 | -524.17 |
EV/EBITDA | 7.68 | 7.35 | 17.03 | 18.76 | 3.89 | 111.11 | -164.13 | |
Debt/Equity | 0.57 | 0.53 | 0.45 | 3.82 | 2.44 | 3.26 | 4.59 | |
Debt/TotalCap | 0.36 | 0.35 | 0.31 | 0.79 | 0.71 | 0.77 | 0.82 | |
EBITDA/IntExps | 6.8 | 8.14 | 13.35 | 1.39 | 4.14 | 0.18 | -0.16 |
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ![]() |
|||||
F Poor | ||||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
MARKET CAPITALIZATION | ||
Listed Share | 11.236.681.881 | |
Price | Rp. 232 | |
Capitalization | Rp. 2.607 B. | |
OWNERSHIP | ||
Listing Date : 16-OCT-2001 | ||
Lokal 34,41 % | Asing 65,59 % | Lainnya 0,00 % |
RATING FUNDAMENTAL | ||
---|---|---|
Rating EPS | 0 | |
Rating ROA | 1 | |
Rating EQUITY | 2 | |
Rating ROE | 0 | |
Rating DER | 2 | |
Rating TOTAL | 1 |
![]() | PYFA - Pyridam Farma Tbk | PYFA - Pyridam Farma Tbk | PYFA - Pyridam Farma Tbk | |
Sector | : | Healthcare | ||
Sub Sector | : | Pharmaceuticals and Health Care Research | ||
Industry | : | Pharmaceuticals | ||
Sub Industry | : | Pharmaceuticals | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Index (4) | : | COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Board | : | 4 Index COMPOSITE, IDXHEALTH, IDXSMC-COM, DBX | ||
Fasilitas Marjin | : | Saham yang tidak dapat diperdagangkan dengan menggunakan fasilitas marjin | ||
Pre Opening | : | Saham dapat diperdagangan melalui sesi Pre-opening | ||
Corporate Action | : | - | ||
TIME PERIOD : 21-05-2025 | |||
Close | 232 | Prev Close | 232 |
Change | - | Range | 232-242 |
Bid | 232 | Offer | 234 |
Bid Volume | 468400 | Offer Volume | 175900 |
Frequency | 1259 | Value Rp.: 3.222.235.000 |
EARNING PER SHARE (% PRICE) | |||||
---|---|---|---|---|---|
Benchmark to Others : | |||||
A Exceptional | |||||
B Excellent | |||||
C Very Good | |||||
D Good | |||||
E Fair | ![]() |
||||
F Poor | |||||
Percent (%) of Price |
≤ 0 |
0-1.05 | 1.05-2.3 | 2.3-4.23 | > 4.23 |
RATING & BTO MATRIX | ||||||
---|---|---|---|---|---|---|
Benchmark to Others : | ||||||
A Exceptional | ||||||
B Excellent | ||||||
C Very Good | ||||||
D Good | ||||||
E Fair | ![]() |
|||||
F Poor | ||||||
RATING | ||||||
RATING | 0 | 1 | 2 | 3 | 4 | 5 |
RATING | 0 | 1 | 2 | 3 | 4 | 5 |